✦ LIBER ✦
High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission
✍ Scribed by Ignazio Majolino; Marco Ladetto; Anna Locasciulli; Daniela Drandi; Fabio Benedetti; Andrea Gallamini; Teodoro Chisesi; Angelo De Blasio; Mario Boccadoro; Corrado Tarella
- Book ID
- 111641090
- Publisher
- Springer US
- Year
- 2006
- Tongue
- English
- Weight
- 117 KB
- Volume
- 23
- Category
- Article
- ISSN
- 1357-0560
No coin nor oath required. For personal study only.